Organization
Rznomics
1 clinical trial
Clinical trial
A Phase 1/2a, Open-label, Multicenter, Dose Escalation and Dose Expansion Study Evaluating the Safety, Tolerability, and Efficacy of RZ-001 in Combination With Valganciclovir in Subjects With GlioblastomaStatus: Not yet recruiting, Estimated PCD: 2029-03-01